Physiologic and pharmacologic role of the glucocorticoid receptor in germinal center B cells and plasmacytic differentiation
Proceedings of the National Academy of Sciences · 17.11.2026 · 123 (46)
DOI: 10.1073/pnas.2624410123 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 11.11.2026. Verfasst von Clarissa Corinaldesi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Cancer Genetics, Columbia University, New York, NY 10032. Hauptthemen laut MEDLINE: Receptors, Glucocorticoid, Germinal Center, Cell Differentiation, Plasma Cells. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Leukemia and Lymphoma Society (LLS), NCI NIH HHS, HHS | NIH | National Cancer Institute (NCI).
Abstract (Originalsprache)
In diffuse large B cell lymphoma (DLBCL), a malignancy derived from germinal center (GC) B cells, somatic hypermutation aberrantly targets glucocorticoid receptor (GR) binding sequences in the super-enhancer (SE) of multiple oncogenes. These events abrogate GR binding and deregulate the expression of the SE-linked gene, suggesting an important role of GR in normal and transformed GC B cells. Using a GC-specific Nr3c1 knockout mouse model and multi-omics analyses in murine and human GC B cells, here we show that, under physiological conditions, GR constitutively localizes to the nucleus, where it transcriptionally modulates signaling pathways implicated in GC homeostasis and plasmablast differentiation in part by antagonizing the repressive function of BCL6 on the plasma cell master regulators IRF4 and PRDM1. While loss of baseline GR activity led to mild GC hyperplasia and impaired plasmacytic differentiation, pharmacologic doses of glucocorticoids, a key component of DLBCL chemo-immunotherapy, were preferentially toxic to GC in a GC B cell–autonomous manner. These findings uncover a physiological role for GR in the GC reaction as well as in promoting plasmablast/plasma cell formation and provide insights into the specific activity of glucocorticoids in the treatment of DLBCL.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Cancer Genetics, Columbia University, New York, NY 10032.
- Department of Otolaryngology, Columbia University, New York, NY 10032.
- Department of Pathology and Cell Biology, Columbia University, New York, NY 10032.
- Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY 10032.
- Department of Genetics and Development, Columbia University, New York, NY 10032.
- Department of Microbiology and Immunology, Columbia University, New York, NY 10032.
ORCID-Profile: Laura Pasqualucci
Förderung
- Leukemia and Lymphoma Society (LLS)
- NCI NIH HHS
- HHS | NIH | National Cancer Institute (NCI)
Zitieren
APA
Corinaldesi, C., Holmes, A. B., Yu, C., Amini-Farsani, Z., Shen, Q., Mo, T., Grunstein, E., Bhagat, G., Basso, K., Dalla-Favera, R., & Pasqualucci, L. (2026). Physiologic and pharmacologic role of the glucocorticoid receptor in germinal center B cells and plasmacytic differentiation. Proceedings of the National Academy of Sciences, 123(46). https://doi.org/10.1073/pnas.2624410123
Vancouver
Corinaldesi C, Holmes AB, Yu C, Amini-Farsani Z, Shen Q, Mo T, et al. Physiologic and pharmacologic role of the glucocorticoid receptor in germinal center B cells and plasmacytic differentiation. Proceedings of the National Academy of Sciences. 2026;123(46). doi:10.1073/pnas.2624410123
BibTeX
@article{Corinaldesi2026,
author = {Corinaldesi, Clarissa and Holmes, Antony B and Yu, Chuanjiang and Amini-Farsani, Zeinab and Shen, Qiong and Mo, Tongwei and Grunstein, Eli and Bhagat, Govind and Basso, Katia and Dalla-Favera, Riccardo and Pasqualucci, Laura},
title = {Physiologic and pharmacologic role of the glucocorticoid receptor in germinal center B cells and plasmacytic differentiation},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {46},
doi = {10.1073/pnas.2624410123}
}
EUVIMED